Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism

US Patent 6376477 · Granted Apr 23, 2002

Estimated economic value: $73,517,000

Assignee

Inventors

View full patent text on Google Patents →